BANK OF AMERICA CORP /DE/
BankPosition in ACHV — Achieve Life Sciences, Inc.
CIK 70858
CHARLOTTE, NC
Position in ACHV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,208,539
+$1,000,729 QoQ
Shares Held
185,075
+161.8% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 111 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. ACHV ranks #207 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ACHV
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,208,539 | 185,075 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $207,810 | 70,684 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $119,547 | 24,054 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $149,337 | 47,409 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $76,231 | 33,731 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $64,383 | 24,114 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $127,311 | 36,168 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $125,173 | 26,408 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $123,806 | 26,342 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $101,714 | 22,355 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $26,911 | 6,532 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $28,031 | 6,519 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $33,833 | 6,519 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $38 | 16 | Shares | Defined | 2023-02-10 | |
| 2021-09-30 | $391 | 46 | Shares | Defined | 2021-11-15 | |
| 2020-12-31 | $202 | 25 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $309 | 37 | Shares | Defined | 2020-11-13 | |
| 2020-03-31 | $2,313 | 7,011 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||